We are live on ! Find out more
CCXI

ChemoCentryx, Inc.
CCXI

Delisted

CCXI was delisted on the 19th of October, 2022.

Back to rankings

1 hedge funds and large institutions have $52 invested in ChemoCentryx, Inc. in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 212 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 217 → 1 (-216)

100% less funds holding in top 10

Funds holding in top 10: 12 → 0 (-12)

100% less capital invested

Capital invested by funds: $3.2B → $52 (-$3.2B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 212

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-216
Holders Change %
-99.54%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-12
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
212
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$311M
2
Goldman Sachs
Goldman Sachs
New York
-$290M
3
BlackRock
BlackRock
New York
-$250M
4
UOC
UBS O'Connor
Illinois
-$141M
5
State Street
State Street
Massachusetts
-$140M
Name Holding Trade Value Shares
Change 		Change in
Stake
N
76
Natixis
France
– -$5.13M -99,206 Closed
RhumbLine Advisers
77
RhumbLine Advisers
Massachusetts
– -$4.86M -94,082 Closed
KC
78
Kellner Capital
New York
– -$4.84M -93,700 Closed
MOACM
79
Mutual of America Capital Management
New York
– -$4.47M -86,576 Closed
Qube Research & Technologies (QRT)
80
Qube Research & Technologies (QRT)
United Kingdom
– -$4.46M -86,359 Closed
RJFSA
81
Raymond James Financial Services Advisors
Florida
– -$4.43M -85,738 Closed
WMSA
82
Weiss Multi-Strategy Advisers
New York
– -$4.05M -78,476 Closed
TCM
83
Tekla Capital Management
Massachusetts
– -$4.04M -78,197 Closed
HA
84
Havens Advisors
New York
– -$3.88M -75,000 Closed
California State Teachers Retirement System (CalSTRS)
85
California State Teachers Retirement System (CalSTRS)
California
– -$3.82M -73,965 Closed
UBS AM
86
UBS AM
Illinois
– -$3.65M -70,721 Closed
HM
87
Harvest Management
New York
– -$3.62M -70,000 Closed
Verition Fund Management
88
Verition Fund Management
Connecticut
– -$3.49M -67,549 Closed
BNP Paribas Financial Markets
89
BNP Paribas Financial Markets
France
– -$3.41M -65,943 Closed
Susquehanna International Group
90
Susquehanna International Group
Pennsylvania
– -$3.25M -62,963 Closed
BHMP
91
Bardin Hill Management Partners
New York
– -$3.24M -62,790 Closed
First Trust Advisors
92
First Trust Advisors
Illinois
– -$3.2M -61,975 Closed
Hudson Bay Capital Management
93
Hudson Bay Capital Management
Connecticut
– -$2.97M -57,500 Closed
Ameriprise
94
Ameriprise
Minnesota
– -$2.88M -55,782 Closed
Legal & General Group
95
Legal & General Group
United Kingdom
– -$2.83M -54,674 Closed
CC
96
Centiva Capital
New York
– -$2.6M -50,300 Closed
LCM
97
Lynwood Capital Management
Ontario, Canada
– -$2.58M -50,000 Closed
TCM
98
Tang Capital Management
California
– -$2.58M -50,000 Closed
AIMCA
99
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$2.56M -49,500 Closed
YCM
100
Yakira Capital Management
Connecticut
– -$2.55M -49,330 Closed
2 3
4
5 6

CCXI Hedge Fund Activity: Q4 2022 in Review

1 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q4 2022, worth a combined $52 — down 100% from $3.2B a quarter earlier.

Sellers outnumbered buyers: 212 funds closed out of CCXI and 0 opened new positions — a net loss of 212 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $311M sold.

  • 1 institutional investor held ChemoCentryx, Inc. (CCXI) as of Q4 2022, down from 217 in Q3 2022.
  • Funds reported $52 of ChemoCentryx, Inc. stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new ChemoCentryx, Inc. positions in Q4 2022 and 212 closed out, a net change of -212 holders.
  • The largest ChemoCentryx, Inc. seller in Q4 2022 was Vanguard Group, an estimated $311M sold.

Based on aggregated 13F filings for Q4 2022.